Neurogesx's IPO

Neurogesx raised a round of funding on May 02, 2007. Investors include Public.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neura…

Articles about Neurogesx's IPO: